Observational Study: Safety and Effectiveness of Obinutuzumab in Chronic Lymphocytic Leukemia in Argentina
Clinical trial NCT03059251 · COMPLETED
Trial details
- NCT number
- NCT03059251
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-08-31
- Primary completion
- 2019-03-30
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.